Ribo submits European CTA for a novel dual targeting siRNA SR122 for mixed and severe dyslipidemia: Suzhou, China Wednesday, November 11, 2026, 18:00 Hrs [IST] Suzhou Ribo Life Sc ...
US FDA declines to approve Novocure’s Optune Mya to treat adult patients with brain metastases from NSCLC: Baar, Switzerland Wednesday, November 11, 2026, 14:00 Hrs [IST] Novocu ...
Merck reports positive results from phase 2b trial of efinopegdutide in adults with MASH and stage 2-3 fibrosis: Rahway, New Jersey Wednesday, November 11, 2026, 15:00 Hrs [IST] M ...
US FDA grants marketing approval to Bayer’s asundexian for secondary stroke risk reduction: Berlin Wednesday, November 11, 2026, 09:00 Hrs [IST] Bayer announced that the US Food ...
Point of care technologies reshaping access to diagnosis across India: Kai Yoshida Wednesday, November 11, 2026, 08:00 Hrs [IST] India’s healthcare system is entering a defining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results